TEST BANK FOR PHARMACOLOGY CLEAR AND SIMPLE- A GUIDE TO DRUG CLASSIFICATIONS AND DOSAGE CALCULATIONS 3RD EDITION WATKINS

TEST BANK FOR PHARMACOLOGY CLEAR AND
SIMPLE- A GUIDE TO DRUG CLASSIFICATIONS
AND DOSAGE CALCULATIONS 3RD EDITION
WATKINS

,TABLE OF CONTENTS
CHAPTER 1. HISTORY OF PHARMACOLOGY .................................................................................................. 3
CHAPTER 2. BASICS OF PHARMACOLOGY ................................................................................................... 22
CHAPTER 3. PATIENT SAFETY IN MEDICATION ADMINISTRATION MULTIPLE CHOICE ............................... 41
CHAPTER 4. REGULATIONS ......................................................................................................................... 57
CHAPTER 5.- PRESCRIPTIONS AND LABELSCHAPTER 6. BASIC REVIEW OF MATHEMATICSCHAPTER ....... 77
7. MEASUREMENT SYSTEMSCHAPTER 8. DOSAGE CALCULATIONS............................................................ 77
CHAPTER 9. ENTERAL MEDICATIONS AND ADMINISTRATION MULTIPLE CHOICE ..................................... 93
CHAPTER 10. PARENTERAL MEDICATIONS AND ADMINISTRATION ......................................................... 106
CHAPTER 11. INTEGUMENTARY SYSTEM MEDICATIONS MULTIPLE CHOICE ........................................... 121
CHAPTER 12. MUSCULOSKELETAL SYSTEM MEDICATIONS ...................................................................... 135
CHAPTER 13. NERVOUS SYSTEM MEDICATIONS....................................................................................... 151
CHAPTER 14. EYE AND EAR MEDICATIONS ............................................................................................... 169
CHAPTER 15. ENDOCRINE SYSTEM MEDICATIONS ................................................................................... 182
CHAPTER 16. CARDIOVASCULAR SYSTEM MEDICATIONS CARDIOTONIC: 1. ............................................ 199
CHAPTER 17. IMMUNOLOGICAL SYSTEM MEDICATIONS ......................................................................... 305
CHAPTER 18. PULMONARY SYSTEM MEDICATIONS ................................................................................. 324
CHAPTER 19. GASTROINTESTINAL SYSTEM MEDICATIONS ...................................................................... 361
CHAPTER 20. REPRODUCTIVE AND URINARY SYSTEMS MEDICATIONS FEMALE REPRODUCTIVE: .......... 394
CHAPTER 21. HERBS, VITAMINS, AND MINERALS ..................................................................................... 447

,PHARMACOLOGY CLEAR AND SIMPLE- A GUIDE TO DRUG CLASSIFICATIONS AND DOSAGE CALCULATIONS
3RD EDITION WATKINS TEST BANK

CHAPTER 1. HISTORY OF PHARMACOLOGY




1. A NURSE WORKING IN RADIOLOGY ADMINISTERS IODINE TO A PATIENT WHO IS HAVING A
COMPUTED TOMOGRAPHY (CT) SCAN. THE NURSE WORKING ON THE ONCOLOGY UNIT ADMINISTERS
CHEMOTHERAPY TO PATIENTS WHO HAVE CANCER. AT THE PUBLIC HEALTH DEPARTMENT, A NURSE
ADMINISTERS A MEASLES-MUMPS-RUBELLA (MMR) VACCINE TO A 14-MONTH-OLD CHILD AS A
ROUTINE IMMUNIZATION. WHICH BRANCH OF PHARMACOLOGY BEST DESCRIBES THE ACTIONS OF ALL
THREE NURSES?

A) PHARMACOECONOMICS

B) PHARMACOTHERAPEUTICS

C) PHARMACODYNAMICS

D) PHARMACOKINETICS

CORRECT ANSWER>>B

FEEDBACK:

PHARMACOLOGY IS THE STUDY OF THE BIOLOGIC EFFECTS OF CHEMICALS. NURSES ARE INVOLVED WITH
CLINICAL PHARMACOLOGY OR PHARMACOTHERAPEUTICS, WHICH IS A BRANCH OF PHARMACOLOGY
THAT DEALS WITH THE USES OF DRUGS TO TREAT, PREVENT, AND DIAGNOSE DISEASE. THE RADIOLOGY
NURSE IS ADMINISTERING A DRUG TO HELP DIAGNOSE A DISEASE. THE ONCOLOGY NURSE IS
ADMINISTERING A DRUG TO HELP TREAT A DISEASE. PHARMACOECONOMICS INCLUDES ANY COSTS
INVOLVED IN DRUG THERAPY. PHARMACODYNAMICS INVOLVES HOW A DRUG AFFECTS THE BODY AND
PHARMACOKINETICS IS HOW THE BODY ACTS ON THE BODY.



2. A PHYSICIAN HAS ORDERED INTRAMUSCULAR (IM) INJECTIONS OF MORPHINE, A NARCOTIC,
EVERY 4 HOURS AS NEEDED FOR PAIN IN A MOTOR VEHICLE ACCIDENT VICTIM. THE NURSE IS AWARE
THIS DRUG HAS A HIGH ABUSE POTENTIAL. UNDER WHAT CATEGORY WOULD MORPHINE BE
CLASSIFIED?

A) SCHEDULE I

B) SCHEDULE II

C) SCHEDULE III

, D) SCHEDULE IV

CORRECT ANSWER>> B




FEEDBACK:

NARCOTICS WITH A HIGH ABUSE POTENTIAL ARE CLASSIFIED AS SCHEDULE II DRUGS BECAUSE OF
SEVERE DEPENDENCE LIABILITY. SCHEDULE I DRUGS HAVE HIGH ABUSE POTENTIAL AND NO ACCEPTED
MEDICAL USE. SCHEDULE III DRUGS HAVE A LESSER ABUSE POTENTIAL THAN II AND AN ACCEPTED
MEDICAL USE. SCHEDULE IV DRUGS HAVE LOW ABUSE POTENTIAL AND LIMITED DEPENDENCE LIABILITY.



3. WHEN INVOLVED IN PHASE III DRUG EVALUATION STUDIES, WHAT RESPONSIBILITIES WOULD
THE NURSE HAVE?

A) WORKING WITH ANIMALS WHO ARE GIVEN EXPERIMENTAL DRUGS

B) CHOOSING APPROPRIATE PATIENTS TO BE INVOLVED IN THE DRUG STUDY

C) MONITORING AND OBSERVING PATIENTS CLOSELY FOR ADVERSE EFFECTS

D) CONDUCTING RESEARCH TO DETERMINE EFFECTIVENESS OF THE DRUG

CORRECT ANSWER>> C

FEEDBACK:

PHASE III STUDIES INVOLVE USE OF A DRUG IN A VAST CLINICAL POPULATION IN WHICH PATIENTS ARE
ASKED TO RECORD ANY SYMPTOMS THEY EXPERIENCE WHILE TAKING THE DRUGS. NURSES MAY BE
RESPONSIBLE FOR HELPING COLLECT AND ANALYZE THE INFORMATION TO BE SHARED WITH THE FOOD
AND DRUG ADMINISTRATION (FDA) BUT WOULD NOT CONDUCT RESEARCH INDEPENDENTLY BECAUSE
NURSES DO NOT PRESCRIBE MEDICATIONS. USE OF ANIMALS IN DRUG TESTING IS DONE IN THE
PRECLINICAL TRIALS. SELECT PATIENTS WHO ARE INVOLVED IN PHASE II STUDIES TO PARTICIPATE IN
STUDIES WHERE THE PARTICIPANTS HAVE THE DISEASE THE DRUG IS INTENDED TO TREAT. THESE
PATIENTS ARE MONITORED CLOSELY FOR DRUG ACTION AND ADVERSE EFFECTS. PHASE I STUDIES
INVOLVE HEALTHY HUMAN VOLUNTEERS WHO ARE USUALLY PAID FOR THEIR PARTICIPATION. NURSES
MAY OBSERVE FOR ADVERSE EFFECTS AND TOXICITY.



4. WHAT CONCEPT IS CONSIDERED WHEN GENERIC DRUGS ARE SUBSTITUTED FOR BRAND NAME
DRUGS?

A) BIOAVAILABILITY